• This email address is being protected from spambots. You need JavaScript enabled to view it.
  • Sun - Fri 8:00 - 20:30
TB Alliance

TB Alliance participates in Indonesia's high-level meeting on tuberculosis

TB Alliance is honored to join today's High-Level Meeting hosted by the Indonesian Ministry of Health. Leaders and experts in tuberculosis (TB) have convened to discuss strategies, innovations, and achievements in the global fight to end TB. The full-day session will bring together a distinguished group of global stakeholders dedicated to addressing and eliminating the TB pandemic.

Read more →
symmetric dimethylarginine

Chung-Ang University creates a non-invasive biosensor for early kidney disease detection

Traditionally, kidney health has been monitored by measuring blood creatinine levels, which indicate muscle breakdown. High creatinine levels can suggest that the kidneys are not filtering waste efficiently. However, creatinine levels can be affected by a person's muscle mass and only rise significantly after more than 75% of kidney function is lost.

Read more →
Dr. Philippe Marambaud

Feinstein Institutes Research Shows Cancer Drugs Could Help With Vascular Disease

A drug commonly used to treat breast cancer might be able to help people living with hereditary hemorrhagic telangiectasia (HHT) – a rare genetic bleeding condition that causes enlargements and tangles of veins and arteries, as well as other malformations of the blood vessels – according to new research from The Feinstein Institutes for Medical Research.

Read more →
BioRise in chamber version 1

Akadeum Life Sciences will showcase advancements for cell therapy workflows at the 2024 Cell and Gene Meeting on the Mesa

Akadeum Life Sciences is excited to announce its participation Mesa, a globally recognized program held at the iconic Arizona Biltmore. This premier program brings together senior executives and key decision-makers from the cell and gene therapy industry to engage in critical discussions, presentations, and partnering sessions aimed at advancing the next generation of therapeutics.

Read more →
Bloomage's

Bloomage 2024 Mid-Year Report highlights growth driven by its strategic transformation into a solutions provider.

Bloomage released its mid-year financial report, reporting a revenue of RMB 2.811 billion (~USD 385 million) for the first half of the year. This success reflects the company's strategic transformation from a traditional raw materials supplier to a solution provider, which has driven significant growth across its raw materials and medical terminal products businesses.

Read more →
CYTOQUBE (C15200-01RGBU) Light-Sheet Microplate Cytometer

Hamamatsu Photonics introduces CYTOQUBE, a new cell analyzer with light-sheet optics and image analysis for fast, user-friendly 3D cell screening assays

Hamamatsu Photonics K.K. (Hamamatsu City, Japan) has developed a new instrument, creating a unique class of cell analyzers. By implementing light-sheet optics and image analysis, in combination with an easy-to-use interface, we have engineered a fast, user-friendly system ideal for 3D cell screening assays.

Read more →